doi:https://doi.org/

References:

Jernberg T., Lindahl B. A combination of troponin T and 12-lead electrocardiography: a valuable tool for early prediction of long-term mortality in patients with chest pain without ST-segment elevation. Am Heart J 2002;144:804—810.
Keller T., Zeller T., Peetz D., et al. Sensitive troponin I assay in early diagnosis of acute myocardial infarction. N Engl J Med 2009;361:868—877.
Polanczyk C.A., Lee T.H., Cook E.F., et al. Cardiac troponin I as a predictor of major cardiac events in emergency department patients with acute chest pain. J Am Coll Cardiol 1998;32:8—14.
Januzzi J.L. Jr, Newby L.K., Murphy S.A., et al. Predicting a late positive serum troponin in initially troponin-negative patients with non—ST-elevation acute coronary syndrome: clinical predictors and validated risk score results from the TIMI IIIB and GUSTO IIA studies. Am Heart J 2006;151:360—366.
Newby L.K., Christenson R.H., Ohman E.M., et al. Value of serial troponin T measures for early and late risk stratification in patients with acute coronary syndromes. The GUSTO-IIa Investigators. Circulation 1998;98:1853—1859.
Cannon C.P., Weintraub W.S., Demopoulos L.A., et al. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med 2001; 344:1879—1887.
Glaser R., Herrmann H.C., Murphy S.A., et al. Benefit of an early invasive management strategy in women with acute coronary syndromes. JAMA 2002;288:3124—3129.
Morrow D.A., Cannon C.P., Rifai N., et al. Ability of minor elevations of troponins I and T to predict benefit from an early invasive strategy in patients with unstable angina and non—ST elevation myocardial infarction: results from a randomized trial. JAMA 2001;286:2405—2412.
Schwartz G.G., Olsson A.G., Ezekowitz M.D., et al. Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial. JAMA 2001;285:1711—1718.
Newby L.K., Kristinsson A., Bhapkar M.V., et al. Early statin initiation and outcomes in patients with acute coronary syndromes. JAMA 2002;287:3087—3095.
Nissen S.E. Pathobiology, not angiography, should guide management in acute coronary syndrome/non-ST-segment elevation myocardial infarction: the non-interventionist’s perspective. J Am Coll Cardiol 2003;41(suppl):103S—112S.
Missel E., Mintz G.S., Carlier S.G., et al. Necrotic core and its ratio to dense calcium are predictors of high-risk non-ST-elevation acute coronary syndrome. Am J Cardiol 2008;101:573—578.
Wu X., Maehara A., Mintz G.S., et al. Virtual histology intravascular ultrasound analysis of non-culprit attenuated plaques detected by grayscale intravascular ultrasound in patients with acute coronary syndromes. Am J Cardiol 2010;105:48—53.
Choi S.H., Chae A., Miller E., et al. Relationship between biomarkers of oxidized low-density lipoprotein, statin therapy, quantitative coronary angiography, and atheroma: volume observations from the REVERSAL (Reversal of Atherosclerosis with Aggressive Lipid Lowering) study. J Am Coll Cardiol 2008;52:24—32.
de Lemos J.A., Blazing M.A., Wiviott S.D., et al. Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial. JAMA 2004;292:1307—1316.
Gibson C.M., Pride Y.B., Hochberg C.P., et al. Effect of intensive statin therapy on clinical outcomes among patients undergoing percutaneous coronary intervention for acute coronary syndrome. PCI-PROVE IT: a PROVE IT-TIMI 22 (Pravastatin or Atorvastatin Evaluation and Infection Therapy — Thrombolysis In Myocardial Infarction 22) substudy. J Am Coll Cardiol 2009;54:2290—2295.
Hiro T., Kimura T., Morimoto T., et al. Effect of intensive statin therapy on regression of coronary atherosclerosis in patients with acute coronary syndrome: a multicenter randomized trial evaluated by volumetric intravascular ultrasound using pitavastatin versus atorvastatin (JAPAN-ACS [Japan assessment of pitavastatin and atorvastatin in acute coronary syndrome] study). J Am Coll Cardiol 2009;54:293—302.
Qian J., Maehara A., Mintz G.S., et al. Relation between individual plaque components and overall plaque burden in the prospective, multicenter virtual histology intravascular ultrasound registry. Am J Cardiol 2009;104:501—506.
Tsimikas S., Witztum J.L., Miller E.R., et al. High-dose atorvastatin reduces total plasma levels of oxidized phospholipids and immune complexes present on apolipoprotein B-100 in patients with acute coronary syndromes in the MIRACL trial. Circulation 2004;110:1406—1412.
Ho P.M., Fihn S.D., Wang L., et al. Clopidogrel and long-term outcomes after stent implantation for acute coronary syndrome. Am Heart J 2007;154:846—851.
Bilodeau M.L., Simon D.I. Clopidogrel for the hot patient. Circ Cardiovasc Interv 2009;2:495—496.
Tricoci P., Roe M.T., Mulgund J., et al. Clopidogrel to treat patients with non—ST-segment elevation acute coronary syndromes after hospital discharge. Arch Intern Med 2006;166:806—811.
Budaj A., Yusuf S., Mehta S.R., et al. Benefit of clopidogrel in patients with acute coronary syndromes without ST-segment elevation in various risk groups. Circulation 2002;106:1622—1626.
Lewis B.S., Mehta S.R., Fox K.A., et al. Benefit of clopidogrel according to timing of percutaneous coronary intervention in patients with acute coronary syndromes: further results from the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) study. Am Heart J 2005;150:1177—1784.
Serruys P.W., Morice M.C., Kappetein A.P., et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med 2009;360:961—972.
Movahed M.R., John J., Hashemzadeh M., Jamal M.M. Trends in the age adjusted mortality from acute ST segment elevation myocardial infarction in the United States (1988 —2004) based on race, gender, infarct location and comorbidities. Am J Cardiol 2009;104:1030—1034.